Ozempic is supposed to be stored refrigerated. The drug packaging, which appeared authentic, featured Chinese writing and the Novo Nordisk logo. In an email, Novo Nordisk said the drug appeared to ...

Ozempic (semaglutide) is a GLP-1 RA (glucagon-like peptide-1 receptor agonist), also known as a “GLP-1” drug. It’s an effective medication for managing type 2 diabetes and for weight loss.

(NEXSTAR) – A woman who used the semaglutide drugs Wegovy and Ozempic to lose weight and treat diabetes says the drugmaker didn’t adequately warn her, or other patients, of the serious side ...

As prices for Ozempic have risen in recent months, many people may be seeking cheaper alternatives for managing diabetes or weight loss. Some doctors, along with the U.S. Food and Drug ...

The sky continues to be the limit for semaglutide, the active ingredient in popular drugs Ozempic and Wegovy. Newly published research is the latest to suggest that semaglutide and other GLP-1 ...

Diabetes and weight loss drugs like Mounjaro and Ozempic may also help patients suffering from addiction, according to a new study. In the study, published Thursday in the scientific journal ...

While plenty of people rave about the weight loss results you can get from drugs like Ozempic, there’s also been a ton of chatter over the fact that these meds are really expensive. These drugs ...

Ozempic (semaglutide) helps people with type 2 diabetes lower their blood sugar if diet, exercise, and other diabetes medications haven’t worked. If you’ve just gotten a prescription for it ...

A new study has found that users of Ozempic or a similar drug had a 40% lower rate of opioid overdose and a 50% lower rate of alcohol intoxication than those without a prescription. Fernanda ...

Dr. Omer Awan is a practicing physician who covers public health. Ozempic, the highly popular GLP-1 agonist drug touted by many celebrities for weight loss, is in short supply, according to its ...

The benefits of Ozempic and similar medications could be profound on a population level. New research has estimated that expanding access to these newer weight loss and diabetes drugs could save ...